SCHEMBL21647719

SCHEMBL21647719

CC(C)(O)CN(c1cccc(Br)c1)S(=O)(=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NR1I2 O75469 9/20 0.50
RORC P51449 3/20 0.50
NR1H2 P55055 4/20 0.48
RORA P35398 2/20 0.45
RORB Q92753 2/20 0.45
NR1H4 Q96RI1 2/20 0.45
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
RXRA P19793 1/20 0.44
SREBF1 P36956 1/20 0.44
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
NR1H3 Q13133 1/20 0.44
NR1I3 Q14994 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21647692 0.80 SMN1; SMN2 (0.60) SMN1; SMN2RORCALDH1A1MAPTMEN1
SCHEMBL1963814 0.78 MEN1 (0.62) ESR1SMN1; SMN2NR1I2RORCALDH1A1
SCHEMBL5731154 0.76 RORC (0.57) ESR1SMN1; SMN2NR1I2RORCNR1H2
SCHEMBL21647723 0.74 SMN1; SMN2 (0.46) ESR1SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL16794196 0.72 PTGER1 (0.54) SMN1; SMN2RORCALDH1A1MEN1KMT2A
SCHEMBL6624409 0.71 ESR1 (0.52) ESR1RORCALDH1A1KMT2ANPSR1
SCHEMBL21647773 0.71 LMNA (0.60) SMN1; SMN2ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL19065098 0.69 HDAC8 (0.64) SMN1; SMN2NR1I2RORCNR1H2RORA
SCHEMBL4610072 0.69 NR1H3 (0.53) ESR1NR1I2NR1H2ALDH1A1NR1H3
SCHEMBL22441784 0.68 LMNA (0.57) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188023-A1 BENZENE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2025-06-12 US disclosed
US-12258308-B2 Benzene derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2025-03-25 US disclosed
CN-112513011-B Benzene derivatives 小野药品工业株式会社 2023-06-16 CN disclosed
US-20220089532-A1 BENZENE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2022-03-24 US disclosed
US-11261154-B2 Benzene derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2022-03-01 US disclosed
US-20210332009-A1 BENZENE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 US disclosed
EP-3831810-A1 BENZENE DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2021-06-09 EP disclosed
CN-112513011-A Benzene derivatives 小野药品工业株式会社 2021-03-16 CN disclosed
WO-2020027150-A1 BENZENE DERIVATIVE 小野薬品工業株式会社 2020-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12258308-B2 Benzene derivative PMP22, TMBIM6, MYT1 ESR1 4559/4885SMN1; SMN2 44/4885NR1I2 1660/4885
US-11261154-B2 Benzene derivative PMP22, TMBIM6, MYT1 ESR1 4559/4885SMN1; SMN2 44/4885NR1I2 1660/4885
US-20250188023-A1 BENZENE DERIVATIVE PMP22, TMBIM6, MYT1 ESR1 4538/4885SMN1; SMN2 49/4885NR1I2 1686/4885
US-20210332009-A1 BENZENE DERIVATIVE PMP22, TMBIM6, MYT1 ESR1 4559/4885SMN1; SMN2 44/4885NR1I2 1660/4885
US-20220089532-A1 BENZENE DERIVATIVE PMP22, TMBIM6, MYT1 ESR1 4559/4885SMN1; SMN2 44/4885NR1I2 1660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.